Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phentermine-Topiramate ER vs Placebo with Wearable Tracker in Obesity
NCT04408586Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity comparing Phentermine-Topiramate ER with Placebo (2 arms). Primary endpoint: Body Weight Change at 3 months. Started Jun 2020; status: completed.
02
Drugs
phentermine + topiramate
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04408586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04408586.